GlassScriptPhysician profile
Kim F Duncan
NPI 1801844097
$22,584.34
in general payments reported to CMS, 2019-2025
4 companies · $3,107 in 2025
The $3,107 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.35 · 2023: $13K · 2024: $6,060 · 2025: $3,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,850.00 |
| Food and Beverage | $708.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integer Holdings Corporation | $21,850.00 | 2023-2025 | Myopore Bipolar Sutureless Myocardial Pacing Lead, Myopore |
| Abbott Laboratories | $327.02 | 2023-2025 | Epic |
| Artivion, INC. | $245.22 | 2021-2023 | Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Atricure, INC. | $162.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.